WTX-921

N/A

Report date: 2025/12/05 16:14:40

Base Information

Drug NameWTX-921
Drug Alias NameWTX-921
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-10 replacements
TargetsInterleukin-10
Therapy Area/IndicationsInflammationInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWerewolf Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesWerewolf Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammationInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A